Nexa News

Researchers at the Global Institute of Medical Sciences have developed ImmunoBoost-25, a revolutionary cancer immunotherapy that has shown promising results in clinical trials. This breakthrough offers new hope for cancer patients worldwide.

Researchers from the Global Cancer Research Institute have announced a significant advancement in cancer immunotherapy with ImmunoBoost-25, which has shown remarkable results in clinical trials. This breakthrough offers new hope to millions of cancer patients worldwide.